![](/img/cover-not-exists.png)
Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease – A report of the NAPRTCS
Vikas R. Dharnidharka, Lynya I. Talley, Karen L. Martz, Donald M. Stablein, Richard N. FineVolume:
12
Year:
2008
Language:
english
Pages:
7
DOI:
10.1111/j.1399-3046.2007.00881.x
File:
PDF, 101 KB
english, 2008